Peace

Home Peace

Todas las noticias

Peace

Jan 15, 2025

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

Peace

Jan 15, 2025

Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters

PLANO,Texas,Jan. 14,2025-- Argon Medical,a leading provider of medical device solutions for Interventional Radiology,Vascular Surgery,Interventional Cardiology,and Oncology procedures,announces the a

Peace

Jan 15, 2025

Supermicro Empowers AI-driven Capabilities for Enterprise, Retail, and Edge Server Solutions

Retailers Can Leverage AI to Increase Revenue and Reduce Costs withSupermicro and NVIDIA\'s Collaboration

Peace

Jan 15, 2025

Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots

Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm\'s bubble-free continuous lamina

Peace

Jan 15, 2025

WiMi Develops a Hybrid CPU-FPGA Quantum AI Simulator

BEIJING,Jan. 15,2025-- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"),a leading global Hologram Augmented Reality ("AR") Technology provider,today anno

Peace

Jan 15, 2025

APPOINTMENT OF ARVIND BHANDARI AS CHAIRMAN AND MANAGING DIRECTOR OF GOODYEAR INDIA

SHANGHAI,Jan. 15,2025-- Goodyear is pleased to announce the appointment of Arvind Bhandari as Chairman andManaging Director of Goodyear India,effective January 2,2025. Based in Delhi,Mr. Bhandari will

1 ... 106 107 108 109 110 111 112 ... 118